Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome. (Q51901174)

17 April 2018

title

Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome. (English)

1 reference

17 April 2018

1 reference

6

1 reference

17 April 2018

Don H. Linszen

7

Don Linszen

1 reference

17 April 2018

Erik Boot

1

Erik Boot

0 references

Lieuwe de Haan

5

Lieuwe de Haan

1 reference

17 April 2018

Thérèse A.M.J. Van Amelsvoort

8

Thérèse van Amelsvoort

1 reference

17 April 2018

author name string

Erik Boot

1

1 reference

17 April 2018

Jan Booij

2

1 reference

17 April 2018

Janneke Zinkstok

3

1 reference

17 April 2018

Nico Abeling

4

1 reference

17 April 2018

language of work or name

English

0 references

publication date

25 July 2007

1 reference

17 April 2018

published in

Neuropsychopharmacology

1 reference

17 April 2018

volume

33

1 reference

17 April 2018

issue

6

1 reference

17 April 2018

page(s)

1252-1258

1 reference

17 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301508

exact match

0 references

cites work

Do we still believe in the dopamine hypothesis? New data bring new evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Possible role for COMT in psychosis associated with velo-cardio-facial syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Velo-cardio-facial syndrome: a review of 120 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

An investigation of the neuropsychological profile in adults with velo-cardio-facial syndrome (VCFS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Increased dopamine transmission in schizophrenia: relationship to illness phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Imaging D2 receptor occupancy by endogenous dopamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Sleep deprivation and impaired cognition. Possible role of brain catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

High rates of schizophrenia in adults with velo-cardio-facial syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Assessment of O-methylated catecholamine levels in plasma and urine for diagnosis of autonomic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Endogenous catecholamines suppress thyrotropin secretion during the early follicular phase of the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Genotyping single-nucleotide polymorphisms by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

The 22q11 deletion syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

A highly significant association between a COMT haplotype and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Dopamine depletion results in increased neostriatal D(2), but not D(1), receptor binding in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

Simultaneous determination of catecholamines and metanephrines in urine by HPLC with fluorometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

7 January 2021

Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

7 January 2021

Prolactin: structure, function, and regulation of secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

7 January 2021

D(1) receptors in prefrontal cells and circuits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

7 January 2021

Behavioral problems in relation to intelligence in children with 22q11.2 deletion syndrome: a matched control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

7 January 2021

Neuropsychiatric disorders in the 22q11 deletion syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

7 January 2021

Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301508

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301508

1 reference

17 April 2018

release_52rihpjlrrejbodpbnj5qgym2u

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/52rihpjlrrejbodpbnj5qgym2u

24 November 2022

mapped directly with Wikidata item

PubMed ID

17653112

1 reference

17 April 2018